Skip to Content
Merck
  • Determination of ticlopidine in human plasma by high-performance liquid chromatography and ultraviolet absorbance detection.

Determination of ticlopidine in human plasma by high-performance liquid chromatography and ultraviolet absorbance detection.

Journal of chromatography. B, Biomedical applications (1995-03-24)
L Dal Bo, F Verga, A Marzo, L Ambrosoli, A Poli
ABSTRACT

A simple HPLC method has been developed for the determination of ticlopidine in human plasma. Plasma samples were buffered at pH 9 and extracted with n-heptane-isoamyl alcohol (98.5:1.5, v/v). Imipramine was used as internal standard. Chromatography was performed isocratically with acetonitrile-methanol-0.05 M KH2PO4 (20:25:55, v/v) at pH 3.0 containing 3% triethylamine at a flow-rate of 1 ml/min. A reversed-phase column, Supelcosil LC-8-DB, 15 cm x 4.6 mm I.D., 5 microns particle size, was used. The effluent was monitored by UV absorbance detection at 235 nm. The method showed good accuracy, precision and linearity in the concentration range 5-1200 ng/ml. The limit of quantitation was 5 ng/ml, with a precision (C.V.) of 8.91%, which is the same as that achieved by other authors with a previously published GC-MS method. The procedure described in this paper is simple and allows the routine assessment of ticlopidine plasma concentration in pharmacokinetic studies following therapeutic doses in human subjects.

MATERIALS
Product Number
Brand
Product Description

Supelco
SUPELCOSIL LC-8-DB HPLC Column, 5 μm particle size, L × I.D. 25 cm × 4 mm
Supelco
SUPELCOSIL LC-8 HPLC Column, 5 μm particle size, L × I.D. 15 cm × 4 mm